Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
248,021
+5,700
+2% +$37.8K 0.41% 50
2026
Q1
$1.26M Buy
242,321
+56,899
+31% +$356K 0.44% 50
2025
Q4
$1.36M Sell
185,422
-87,850
-32% -$851K 0.42% 41
2025
Q3
$2.72M Buy
273,272
+10,699
+4% +$118K 0.88% 21
2025
Q2
$2.38M Sell
262,573
-2,685
-1% -$17.5K 0.89% 20
2025
Q1
$1.7M Sell
265,258
-2,743
-1% -$24.4K 0.72% 28
2024
Q4
$2.55M Sell
268,001
-12,572
-4% -$110K 0.91% 18
2024
Q3
$2.29M Buy
280,573
+18,858
+7% +$196K 0.8% 21
2024
Q2
$3.54M Buy
261,715
+93,486
+56% +$782K 1.28% 12
2024
Q1
$1.18M Buy
168,229
+51,943
+45% +$451K 0.43% 47
2023
Q4
$1.27M Buy
116,286
+4,342
+4% +$42.6K 0.48% 51
2023
Q3
$1.23M Buy
111,944
+17,714
+19% +$253K 0.61% 38
2023
Q2
$1.49M Buy
94,230
+1,886
+2% +$21.9K 0.65% 32
2023
Q1
$1.2M Buy
92,344
+40,343
+78% +$331K 0.62% 39
2022
Q4
$566K Buy
+52,001
New +$640K 0.32% 72

Other funds holding ENVX

Wealth Effects's ENVX Position: Q2 2026 in Review

Wealth Effects increased its Enovix (ENVX) stake by 2.4% in Q2 2026, buying an estimated $37.8K and bringing the position to 248,021 shares worth $1.51M. The position accounts for 0.41% of the portfolio, ranked #50.

Wealth Effects first reported a position in ENVX in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.54M in Q2 2024. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • Wealth Effects held 248,021 shares of Enovix worth $1.51M as of Q2 2026.
  • Wealth Effects bought 5,700 Enovix shares in Q2 2026, an estimated $37.8K.
  • Enovix made up 0.41% of Wealth Effects's portfolio in Q2 2026, its #50 holding.
  • Wealth Effects first reported a position in Enovix in Q4 2022 and has held it in 15 quarters since.
  • Wealth Effects's Enovix position peaked at $3.54M in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on Wealth Effects's 13F filing for Q2 2026, filed 6 Aug 2026.